A scalable 3D tissue culture pipeline to enable functional therapeutic screening for pulmonary fibrosis
Open Access
- 16 November 2021
- journal article
- research article
- Published by AIP Publishing in APL Bioengineering
- Vol. 5 (4) , 046102
Abstract
Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease targeting the alveolar gas exchange apparatus, leading to death by asphyxiation. IPF progresses on a tissue scale through aberrant matrix remodeling, enhanced cell contraction, and subsequent microenvironment densification. Although two pharmaceuticals modestly slow progression, IPF patient survival averages less than 5 years. A major impediment to therapeutic development is the lack of high-fidelity models that account for the fibrotic microenvironment. Our goal is to create a three-dimensional (3D) platform to enable lung fibrosis studies and recapitulate IPF tissue features. We demonstrate that normal lung fibroblasts encapsulated in collagen microspheres can be pushed toward an activated phenotype, treated with FDA-approved therapies, and their fibrotic function quantified using imaging assays (extracellular matrix deposition, contractile protein expression, and microenvironment compaction). Highlighting the system's utility, we further show that fibroblasts isolated from IPF patient lungs maintain fibrotic phenotypes and manifest reduced fibrotic function when treated with epigenetic modifiers. Our system enables enhanced screening due to improved predictability and fidelity compared to 2D systems combined with superior tractability and throughput compared to 3D systems.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (F31 HL151028)
- National Heart, Lung, and Blood Institute (T32 HL07741)
- National Heart, Lung, and Blood Institute (R21 HL132256)
- National Heart, Lung, and Blood Institute (R01 HL125236)
- National Nanotechnology Coordination Office (ECCS-1542202)
This publication has 62 references indexed in Scilit:
- Epidemiology of idiopathic pulmonary fibrosisClinical Epidemiology, 2013
- The myofibroblast matrix: implications for tissue repair and fibrosisThe Journal of Pathology, 2012
- Pulmonary fibrosis: patterns and perpetratorsJournal of Clinical Investigation, 2012
- miR-29 Is a Major Regulator of Genes Associated with Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Feedback amplification of fibrosis through matrix stiffening and COX-2 suppressionJournal of Cell Biology, 2010
- Pirfenidone in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2009
- Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosisJournal of Experimental Medicine, 2008
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The International Journal of Biochemistry & Cell Biology, 2008
- The Global Burden of Disease Due to Outdoor Air PollutionJournal of Toxicology and Environmental Health, Part A, 2005
- Fibroblast‐populated collagen microsphere assay of cell traction force: Part 1. Continuum modelAIChE Journal, 1993